Background: Poor health-related quality of life (HRQL) is common in heart failure (HF), but
there are few data on HRQL in HF and the association between HRQL and mortality outside …

Background Improving symptoms is a primary treatment goal in patients with obstructive
hypertrophic cardiomyopathy. Currently available pharmacological options for hypertrophic …

Background With the advancement in diagnostics and clinical management, patients with
Tetralogy of Fallot (ToF) are surviving till adulthood. Hence, assessing the impact of ToF …

Objectives This study aims to examine the association between the Kansas City
Cardiomyopathy Questionnaire (KCCQ)-12 score and the 30-day and 1-year rates of …

Heart failure (HF) remains a leading cause of mortality and morbidity and a primary driver of
health care resource use in the United States. As such, there continues to be much interest …

ABSTRACT In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT),
tafamidis significantly reduced all-cause mortality and cardiovascular-related …

Objectives This study sought to better understand out-of-hospital 30-day mortality following
transfemoral transcatheter aortic valve replacement (TAVR) and identify factors associated …

Abstract Purpose of Review As medicine strives to become more patient-centered, patient-
reported outcomes (PROs) are often used to describe patients' symptoms, function, and …

Introduction Evaluation of health status benefits, cost-effectiveness, and value of new heart
failure therapies is critical for supporting their use. The Kansas City Cardiomyopathy …

Background: The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been
psychometrically evaluated in multiple heart failure (HF) populations, but the comparability …